It is one of the biggest problems with the biotech market in Australia. Biotech needs patient long term capital that is happy to see a program mature over years, and yet it attracts the hottest money of any sector - even highly speculative nanocap resource companies have more long term holders than the average listed biotech. I wish I knew how to solve this as it is really important for our future as a country.
RAC - Charts & Price Action, page-286
-
- There are more pages in this discussion • 21,243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
-0.070(3.85%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.84 | $1.74 | $363.6K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 716 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 1767 | 3 |
View Market Depth
| Last trade - 14.57pm 02/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |